These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30513231)

  • 41. Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity.
    Wilens TE; Kwon A; Tanguay S; Chase R; Moore H; Faraone SV; Biederman J
    Am J Addict; 2005; 14(4):319-27. PubMed ID: 16188712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).
    Kronenberg LM; Goossens PJ; van Etten DM; van Achterberg T; van den Brink W
    Perspect Psychiatr Care; 2015 Jan; 51(1):4-15. PubMed ID: 24410895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early-age clinical and developmental features associated to Substance Use Disorders in Attention-Deficit/Hyperactivity Disorder in Adults.
    Nogueira M; Bosch R; Valero S; Gómez-Barros N; Palomar G; Richarte V; Corrales M; Nasillo V; Vidal R; Casas M; Ramos-Quiroga JA
    Compr Psychiatry; 2014 Apr; 55(3):639-49. PubMed ID: 24411652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features.
    Spera V; Pallucchini A; Maiello M; Carli M; Maremmani AGI; Perugi G; Maremmani I
    Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32429586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.
    Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA
    Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnosing ADHD in adults with substance use disorder: DSM-IV criteria and differential diagnosis.
    Levin FR; Upadhyaya HP
    J Clin Psychiatry; 2007 Jul; 68(7):e18. PubMed ID: 17685729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms.
    Kaye S; Gilsenan J; Young JT; Carruthers S; Allsop S; Degenhardt L; van de Glind G; van den Brink W
    Drug Alcohol Depend; 2014 Nov; 144():70-7. PubMed ID: 25193717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The dark side of ADHD - comorbidity with substance use disorder and criminality - an overview].
    Johansson Capusan A; Guterstam J; Ginsberg Y; Borg Skoglund L
    Lakartidningen; 2022 Feb; 119():. PubMed ID: 36794414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Irish adolescents with ADHD and comorbid substance use disorder.
    Edokpolo O; Nkire N; Smyth BP
    Ir J Psychol Med; 2010 Sep; 27(3):148-151. PubMed ID: 30282206
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment strategies for co-occurring ADHD and substance use disorders.
    Mariani JJ; Levin FR
    Am J Addict; 2007; 16 Suppl 1(Suppl 1):45-54; quiz 55-6. PubMed ID: 17453606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Adolescents with Concurrent Substance Use Disorder and Attention-Deficit/Hyperactivity Disorder: A Systematic Review.
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens A; Dalsgaard S; van den Brink W; Hendriks V
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adult Attention-Deficit Hyperactivity Disorder/Substance Use Disorder Dual Disorder Patients: A Dual Disorder Unit Point of View.
    Maremmani I; Spera V; Maiello M; Maremmani AGI; Perugi G
    Curr Top Behav Neurosci; 2022; 57():179-198. PubMed ID: 35507285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroimaging the neural correlates of increased risk for substance use disorders in attention-deficit/hyperactivity disorder-A systematic review.
    Adisetiyo V; Gray KM
    Am J Addict; 2017 Mar; 26(2):99-111. PubMed ID: 28106934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of substance use disorder on ADHD and its treatment.
    Wilens TE; Upadhyaya HP
    J Clin Psychiatry; 2007 Aug; 68(8):e20. PubMed ID: 17876905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder.
    Perugi G; Vannucchi G
    Expert Opin Pharmacother; 2015; 16(14):2193-204. PubMed ID: 26364896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues.
    Wilens TE
    Psychiatr Clin North Am; 2004 Jun; 27(2):283-301. PubMed ID: 15063998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [ADHD in Adults and Comorbid Substance Use Disorder: Prevalence, Clinical Diagnostics and Integrated Therapy].
    Dirks H; Scherbaum N; Kis B; Mette C
    Fortschr Neurol Psychiatr; 2017 Jun; 85(6):336-344. PubMed ID: 28645126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Utility of the CPT in the Diagnosis of ADHD in Individuals with Substance Abuse: A Systematic Review.
    Slobodin O
    Eur Addict Res; 2020; 26(4-5):283-294. PubMed ID: 32535592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacotherapy of adolescent substance use disorders: a review of the literature.
    Waxmonsky JG; Wilens TE
    J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):810-25. PubMed ID: 16262597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis and treatment of patients with comorbid substance use disorder and adult attention-deficit and hyperactivity disorder: a review of recent publications.
    van der Burg D; Crunelle CL; Matthys F; van den Brink W
    Curr Opin Psychiatry; 2019 Jul; 32(4):300-306. PubMed ID: 31008730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.